The Enterprise Value as of September 2024 (TTM) for ACADIA Pharmaceuticals Inc. (ACAD) is 2.55B

According to ACADIA Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.55B. This represents a change of -26.21% compared to the average of 3.45B of the last 4 quarters.

ACADIA Pharmaceuticals Inc. (ACAD) Historical Enterprise Value (quarterly & annually)

How has ACAD Enterprise Value performed in the past?

The mean historical Enterprise Value of ACADIA Pharmaceuticals Inc. over the last ten years is 4.06B. The current 2.55B Enterprise Value has changed 6.17% with respect to the historical average. Over the past ten years (40 quarters), ACAD's Enterprise Value was at its highest in in the December 2020 quarter at 8.23B. The Enterprise Value was at its lowest in in the June 2018 quarter at 1.83B.

ACADIA Pharmaceuticals Inc. (ACAD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ACADIA Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ACADIA Pharmaceuticals Inc. (ACAD) Average Enterprise Value

How has ACAD Enterprise Value performed in the past?

The current Enterprise Value of ACADIA Pharmaceuticals Inc. (ACAD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ACADIA Pharmaceuticals Inc. (ACAD) Enterprise Value vs. Peers

How is ACAD’s Enterprise Value compared to its peers?

ACADIA Pharmaceuticals Inc.’s Enterprise Value is less than Madrigal Pharmaceuticals, Inc. (4.91B), less than Viking Therapeutics, Inc. (5.95B), less than Sarepta Therapeutics, Inc. (13.28B), greater than Hepion Pharmaceuticals, Inc. (2.24M), greater than PTC Therapeutics, Inc. (2.17B), greater than Reviva Pharmaceuticals Holdings, Inc. (39.93M), greater than Athira Pharma, Inc. (-59982909.00), greater than Fortress Biotech, Inc. (52.60M), greater than Cabaletta Bio, Inc. (36.88M), greater than Intercept Pharmaceuticals, Inc. (915.81M), greater than Terns Pharmaceuticals, Inc. (458.36M), greater than Akero Therapeutics, Inc. (1.56B), less than Reata Pharmaceuticals, Inc. (6.68B), less than Krystal Biotech, Inc. (4.95B), less than Blueprint Medicines Corporation (6.16B),

Build a custom stock screener for ACADIA Pharmaceuticals Inc. (ACAD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ACADIA Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ACADIA Pharmaceuticals Inc. (ACAD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ACADIA Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.